What is Haemonetics's blood center — total net revenues?

Haemonetics (HAE) reported blood center — total net revenues of $113.12M in Q4 2025.

How has Haemonetics's blood center — total net revenues changed year-over-year?

Haemonetics's blood center — total net revenues decreased by 19.6% year-over-year, from $140.69M to $113.12M.

What does blood center — total net revenues mean?

Represents the total gross revenue generated by the Blood Center segment after deductions for returns, allowances, and discounts. This is the primary top-line metric for the segment, reflecting its market demand and pricing power. It serves as the baseline for evaluating the segment's market share and overall contribution to the corporate revenue stream.

Haemonetics HAE Blood Center — Total net revenues

Other product segments

Hospital

$287M-0.3%

Plasma

$130.29M+2.8%

Similar metrics at other companies

RJFBank — Total net revenues

$486M+12.0%

WBSConsumer Banking — Total segment revenues

$231.51M+1.4%

USBConsumer And Business Banking — Total net revenue

$2.33B+1.2%

AMPCorporate & Other — Total net revenues

$107M-4.5%

THCTotal — Net operating revenues

$3.47B-0.2%

CBUBanking And Corporate Services — Revenues Net Of Interest Expense

$156.33M+12.5%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's blood center — total net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's blood center — total net revenues?: Haemonetics (HAE) reported blood center — total net revenues of $113.12M in Q4 2025.
How has Haemonetics's blood center — total net revenues changed year-over-year?: Haemonetics's blood center — total net revenues decreased by 19.6% year-over-year, from $140.69M to $113.12M.
What does blood center — total net revenues mean?: Represents the total gross revenue generated by the Blood Center segment after deductions for returns, allowances, and discounts. This is the primary top-line metric for the segment, reflecting its market demand and pricing power. It serves as the baseline for evaluating the segment's market share and overall contribution to the corporate revenue stream.